PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

SynGAP Research Fund (SRF) appoints Kathryn Helde, PhD, as Chief Scientific Officer (CSO) focusing on SYNGAP1 research

SynGAP Research Fund (SRF) appoints Kathryn Helde, PhD, as Chief Scientific Officer (CSO) focusing on SYNGAP1 research
2024-04-04
(Press-News.org) Mill Valley, CA – April 4, 2024 – SynGAP Research Fund 501(c)(3), the leading patient advocacy group working to improve the lives of SYNGAP1-Related Disorder (SRD) patients, today announced the appointment of Kathryn Helde, PhD, as its Chief Scientific Officer, effective February 1, 2024.  

“SRF’s scientific grantmaking, industry partnerships, and repurposing efforts have grown past the point where we need a dedicated CSO,” says Mike Graglia, SRF’s Co-Founder and Managing Director.  “We are fortunate to have a parent in our ranks who is as well trained, talented, and dedicated as Dr. Helde.  As a volunteer for years, she has already contributed heavily to the work of the Fund on behalf of our patients and has relationships with numerous partners.”

Dr. Helde shared “I am honored to take a larger role within the SRF team of dedicated parents and caregivers. I especially look forward to curating patient data. I am committed to bringing the patient experience to our partners in research and development.”  

The SRF Board of Directors resoundingly approved the appointment of Dr. Helde.  “We are fortunate to have such a qualified CSO who both understands the nuances of genetics and is experienced in raising an individual with SRD,” stated Suzanne Jones, SRF’s Board of Directors Chairperson.  

Kathryn Helde is committed to SRF’s mission to accelerate the development and availability of disease-modifying therapies for those living with SRD. “I am excited to be in a position to connect with scientists and industry partners working on SYNGAP1 biology, structure, diagnostics, and therapies. With the explosion of SYNGAP1 research and treatment development, it is our goal to identify the actions that will make the biggest difference to the lives of our affected loved ones and their families, as soon as possible.” Both children and adults affected by SRD are living with a deficit of SynGAP protein. The sooner cells receive sufficient SynGAP, the sooner symptoms like epilepsy, intellectual disability, and sensory distress may be alleviated. Time is brain.

About Kathryn Helde Kathryn Helde comes to the role of CSO with the perspective of a developmental biologist and geneticist. Helde graduated from Princeton University in 1988 with a degree in Molecular Biology. She was an early contributor to methods and insights in zebrafish as a model for vertebrate embryogenesis, during her graduate work (U. of Utah, 1995 PhD in Human Genetics), postdoctoral fellowship (U. Washington, 1995-1999 in Pharmacology), and as a Research Scientist (Fred Hutchinson Cancer Research Center, 2008-2013). Helde’s experience with developmental molecular genetics informs her approach to understanding how DNA variants cause SYNGAP1-Related Disorders (SRD) and how SRD can be treated. 

Responsibilities as CSO SRF’s CSO is responsible for managing grants, partnering with SRF’s leadership to engage industry and encourage investment in SRD treatments, liaising with the Clinical and Scientific Advisory Boards, leading SRF’s Family Network efforts to promote the success of clinical trials with appropriate biomarkers and measurable outcomes, as well as supporting scientific communication to the community of affected families.

About SYNGAP1-Related Disability (SRD) SYNGAP1-related intellectual disability (ICD-10 F78.A1; ICD-11 LD90.Y) is an ultra-rare genetic disorder caused by variants on the SYNGAP1 gene that reduce SynGAP protein levels. SRF has identified over 1,400 patients to date, the number grows weekly. This protein acts as a regulator in the synapses (where neurons communicate with each other). When SynGAP protein levels are too low, we see an increase in excitability in the synapses making it difficult for neurons to communicate effectively. This leads to many neurological issues seen in SynGAP patients. Other locations and functions of SynGAP protein are also under study.

Symptoms of SYNGAP1 include: intellectual disability; epilepsy; hypotonia (low muscle tone); gross and fine motor skill delays; autism spectrum disorder; gastro-intestinal disorders; sleep and behavior disorders, and visual abnormalities. 

About the SynGAP Research Fund (SRF) The mission of the SynGAP Research Fund (SRF) is to improve the quality of life for SYNGAP1 patients through the research and development of treatments, therapies, and support systems. 

SRF was founded in the US in 2018 as a 501(c)(3) US public charity, and families created sister organizations for SRF in the UK in 2020, in Europe (Netherlands) in 2022, and in Latin America (Colombia) in 2023. 

Completely family-led, SRF is the largest non-government funder of SYNGAP1 research, having committed over $5 million in grants in just five years. The vast majority of  donations fund science and patient-related programs. SRF’s grant program awards one or two-year grants to investigators, physician residents, and clinicians interested in studying SYNGAP1. SRF grants are intended to help researchers explore novel ideas and answer open questions related to the clinical aspects of and therapies for SRID. 

SRF is a member of FasterCures, COMBINEDbrain, Global Genes Foundation Alliance, Everylife Foundation Community Congress, Epilepsies Action Network, Personalized Medicine Coalition, Rare Epilepsy Network, and the Epilepsy Leadership Council.

For more on SRF, visit cureSYNGAP1.org or follow @cureSYNGAP1 on LinkedIn, YouTube, Instagram, Facebook, TikTok and X.

END

[Attachments] See images for this press release:
SynGAP Research Fund (SRF) appoints Kathryn Helde, PhD, as Chief Scientific Officer (CSO) focusing on SYNGAP1 research SynGAP Research Fund (SRF) appoints Kathryn Helde, PhD, as Chief Scientific Officer (CSO) focusing on SYNGAP1 research 2

ELSE PRESS RELEASES FROM THIS DATE:

Recent contact with young children linked to trebling of risk of over-60s acquiring pneumonia-causing bacteria

2024-04-04
Findings from US longitudinal household study add to ongoing US vaccination policy discussions by suggesting that pneumococcal vaccination in older adults is important even in populations where children are vaccinated at high rates. **Note: the release below is a special early release from the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024, Barcelona, Spain, 27-30 April). Please credit the congress if you use this story** New research being presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) finds that pneumonia-causing ...

Dartmouth researchers map how the brain regulates emotions

2024-04-03
Ever want to scream during a particularly bad day, but then manage not to? Thank the human brain and how it regulates emotions, which can be critical for navigating everyday life. As we perceive events unfolding around us, the ability to be flexible and reframe a situation impacts not only how we feel, but also our behavior and decision-making. In fact, some of the problems associated with mental health relate to individuals' inability to be flexible, such as when persistent negative thoughts make it hard to perceive a situation differently. To help address such issues, a new Dartmouth-led ...

Better nutrition can lead to better brain health, GSA publication shows

2024-04-03
“Insights & Implications in Gerontology: The Vital Role of Nutrition in Brain Health,” a new publication from the Gerontological Society of America, explores nutritional choices that have been shown to improve cognition and decrease the risk of cognitive impairment and dementia in older adults. Consumption of a healthful diet is a behavioral strategy that can help to prevent the development of dementia as people age, the publication says. It also reports on the roles of vitamins and minerals in nutrition and brain function and focuses on how to implement person-centered conversations about the impact of diet and nutrition on overall wellness, including brain ...

Women with serious mental illness want pregnancy information, resources from mental health providers

2024-04-03
Women with serious mental illness (SMI) who are pregnant or planning a pregnancy face gaps in information, support and resources in mental health services, new research suggests. The findings, published April 1 in the peer-reviewed journal Health Affairs, highlight the need to integrate pregnancy and parenting interventions, education, and other resources for women with SMI into mental health services. Policies that increase mental health provider and clinic capacity to address pregnancy and parenting can dramatically improve care for women living with mental ...

Out of the park: new research tallies total carbon impact of tourism at Yellowstone

Out of the park: new research tallies total carbon impact of tourism at Yellowstone
2024-04-03
People depend on natural ecosystems of trees, grasses and shrubs to capture carbon from the atmosphere and pull it underground to slow the decline toward climate-change disaster. Ironically, these same protected spaces also tend to be highly photogenic hot-spots for tourism. New research from the Quinney College of Natural Resources and the Institute of Outdoor Recreation and Tourism makes a case study of one such place — Yellowstone National Park — to calculate surplus carbon visitors from across the world add to the atmosphere each year as a direct ...

Paper: Policy reforms urgently needed to mitigate racial disparities in perinatal mental health conditions

Paper: Policy reforms urgently needed to mitigate racial disparities in perinatal mental health conditions
2024-04-03
CHAMPAIGN, Ill. — A team of researchers is calling for comprehensive changes to U.S. health care and social policies to improve diagnosis and treatment of perinatal mental health conditions and mitigate the dramatic disparities that put women of color at significantly greater risks of morbidity and mortality compared with white women. In a commentary published in the journal Health Affairs, the researchers proposed seven comprehensive changes to health care and economic policies to mitigate the burden of undiagnosed and untreated perinatal mental health challenges that are greatest among racial ...

MIT researchers discover “neutronic molecules”

MIT researchers discover “neutronic molecules”
2024-04-03
Neutrons are subatomic particles that have no electric charge, unlike protons and electrons. That means that while the electromagnetic force is responsible for most of the interactions between radiation and materials, neutrons are essentially immune to that force. Instead, neutrons are held together inside an atom’s nucleus solely by something called the strong force, one of the four fundamental forces of nature. As its name implies, the force is indeed very strong, but only at very close range — it drops off so rapidly as to be negligible beyond 1/10,000 the size of an atom. But now, researchers at MIT have found that neutrons can actually be made to cling ...

Extending Medicaid coverage after birth may increase postpartum treatment for depression, anxiety

2024-04-03
Extending postpartum Medicaid eligibility extensions may increase treatment for perinatal mood and anxiety disorders (PMADs), a leading cause of perinatal illness and mortality, according to a new study led by Boston University School of Public Health (BUSPH) and Brown University researchers. Published in the journal Health Affairs, the study found that retaining Medicaid coverage after birth increased outpatient mental health and medication treatment for PMADs by 20.5 percentage points, compared to birthing people who received commercial coverage. Retaining postpartum Medicaid also appeared to significantly lower patients’ out-of-pocket spending ...

UTA chemist acclaimed as up-and-coming scientist

UTA chemist acclaimed as up-and-coming scientist
2024-04-03
A University of Texas at Arlington chemist has been honored for his significant contributions to separation science. Kevin Schug, the Shimadzu Distinguished Professor of Analytical Chemistry, was named recipient of the 2024 Silver Jubilee Medal by the Chromatography Society, a United Kingdom-based organization with worldwide membership. The Silver Jubilee Medal recognizes up-and-coming researchers who have made major use of separation science in their own field or those who have made important contributions to a particular area of separation science. The award was created in 1982 to celebrate the society’s 25th anniversary. “I know many prominent separation scientists ...

'Smart swarms' of tiny robots inspired by natural herd mentality

2024-04-03
In natural ecosystems, the herd mentality plays a major role – from schools of fish, to beehives to ant colonies. This collective behavior allows the whole to exceed the sum of its parts and better respond to threats and challenges.  This behavior inspired researchers from The University of Texas at Austin, and for more than a year they've been working on creating "smart swarms" of microscopic robots. The researchers engineered social interactions among these tiny machines so that they can act as one coordinated group, performing tasks better than they would if they were moving as individuals ...

LAST 30 PRESS RELEASES:

Nipah virus: epidemiology, pathogenesis, treatment, and prevention

FDA ban on Red Dye 3 and more are highlighted in Sylvester Cancer's January tip sheet

Mapping gene regulation

Exposure to air pollution before pregnancy linked to higher child body mass index, study finds

Neural partially linear additive model

Dung data: manure can help to improve global maps of herbivore distribution

Concerns over maternity provision for pregnant women in UK prisons

UK needs a national strategy to tackle harms of alcohol, argue experts

Aerobic exercise: a powerful ally in the fight against Alzheimer’s

Cambridge leads first phase of governmental project to understand impact of smartphones and social media on young people

AASM Foundation partners with Howard University Medical Alumni Association to provide scholarships

Protective actions need regulatory support to fully defend homeowners and coastal communities, study finds

On-chip light control of semiconductor optoelectronic devices using integrated metasurfaces

America’s political house can become less divided

A common antihistamine shows promise in treating liver complications of a rare disease complication

Trastuzumab emtansine improves long-term survival in HER2 breast cancer

Is eating more red meat bad for your brain?

How does Tourette syndrome differ by sex?

Red meat consumption increases risk of dementia and cognitive decline

Study reveals how sex and racial disparities in weight loss surgery have changed over 20 years

Ultrasound-directed microbubbles could boost immune response against tumours, new Concordia research suggests

In small preliminary study, fearful pet dogs exhibited significantly different microbiomes and metabolic molecules to non-fearful dogs, suggesting the gut-brain axis might be involved in fear behavior

Examination of Large Language Model "red-teaming" defines it as a non-malicious team-effort activity to seek LLMs' limits and identifies 35 different techniques used to test them

Most microplastics in French bottled and tap water are smaller than 20 µm - fine enough to pass into blood and organs, but below the EU-recommended detection limit

A tangled web: Fossil fuel energy, plastics, and agrichemicals discourse on X/Twitter

This fast and agile robotic insect could someday aid in mechanical pollination

Researchers identify novel immune cells that may worsen asthma

Conquest of Asia and Europe by snow leopards during the last Ice Ages uncovered

Researchers make comfortable materials that generate power when worn

Study finding Xenon gas could protect against Alzheimer’s disease leads to start of clinical trial

[Press-News.org] SynGAP Research Fund (SRF) appoints Kathryn Helde, PhD, as Chief Scientific Officer (CSO) focusing on SYNGAP1 research